Breaking News

Middough, Toyo Engineering In Bio-Project Pact

April 19, 2013

Will offer pharma and biopharma engineering solutions in Asia

Middough Inc., a U.S. engineering, architecture, and management services company, has signed an alliance agreement with Toyo Engineering Corp. of Japan to develop and execute biopharmaceutical capital projects in Asia. Middough will combine its pharma and biopharma technical expertise with Toyo’s engineer-procure-construct project delivery capabilities in Asia. Middough will provide technology transfer services to Toyo staff based in Japan and China. The alliance allows both companies to serve global clients requiring pharma and biopharma expertise and engineering solutions in Asia.
 
“We are excited to be leveraging in-country bases of operation to serve this market with our established skills and expertise in biopharmaceuticals,” said Charles K. Dietz, general manager and senior vice president of Middough’s Life Science Business.  “Toyo, Middough and our clients will all gain from this Teaming Agreement by expanding our technical and geographic reach to the rapidly developing biopharmaceutical manufacturing sector in Asia.”
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.